BioViva Science Competitors and Similar CompaniesClear all
BioViva Science's competitors and similar companies include Orchard Therapeutics, CAMP4 Therapeutics, Affinia Therapeutics and Nouscom.
 BioViva Science BioViva Science is a biotech company, which develops and licenses gene therapies and procedures for cellular degeneration and genetic disorders. |  Orchard Therapeutics Orchard Therapeutics is a biotechnology company that develops transformative ex vivo autologous hematopoietic stem cell gene therapy. |  CAMP4 Therapeutics CAMP4 Therapeutics is a biotechnology company that develops antisense oligonucleotide therapeutics targeting gene expression. |  Nouscom Nouscom is a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.
| ||
Founding Date | Founding Date 2015 | Founding Date 2015 | Founding Date 2016 | Founding Date 2019 | Founding Date 2015 |
Type | Type Private | Type Subsidiary | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Seattle, US HQ | Locations London, GB HQ Boston, US Boston, US Foster City, US Menlo Park, US | Locations Cambridge, US HQ | Locations Waltham, US HQ | Locations Basel, CH HQ Roma, IT |
Employees | Employees 4 | Employees 166 | Employees 66 | Employees 613% decrease | Employees 633% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $22.7m (FY, 2022) | Revenue (est.) $3.5m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($150.7m) (FY, 2022) | Net income ($80.4m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 60m (about 6 years ago) | Latest funding round $ 49m (over 8 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 310.7m | Total funding raised $ 30m | Total funding raised $ 60m | Total funding raised $ 62.6m |
For sources of this data, please see the company profile
View Company Profiles
Orchard Therapeutics
HQ
London, GB
Orchard Therapeutics is a biotechnology company that develops transformative ex vivo autologous hematopoietic stem cell gene therapy.
View companyCAMP4 Therapeutics
HQ
Cambridge, US
Employees
66
CAMP4 Therapeutics is a biotechnology company that develops antisense oligonucleotide therapeutics targeting gene expression.
View company
Affinia Therapeutics
HQ
Waltham, US
Employees
61↓ 3% decrease
Affinia Therapeutics is a biotech company.
View companyNouscom
HQ
Basel, CH
Employees
63↑ 3% increase
Nouscom is a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.
View company